As of 2025-06-30, the Intrinsic Value of Pliant Therapeutics Inc (PLRX) is -17.88 USD. This PLRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.25 USD, the upside of Pliant Therapeutics Inc is -1,530.30%.
Based on its market price of 1.25 USD and our intrinsic valuation, Pliant Therapeutics Inc (PLRX) is overvalued by 1,530.30%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.88 - -17.88 | -17.88 | -1,530.30% |
| P/E | (67.65) - (66.51) | (67.85) | -5528.0% |
| DDM - Stable | (47.17) - (227.73) | (137.45) | -11096.3% |
| DDM - Multi | (1.85) - (6.81) | (2.90) | -331.6% |
| Market Cap (mil) | 76.74 |
| Beta | 1.23 |
| Outstanding shares (mil) | 61.39 |
| Enterprise Value (mil) | 15.09 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.36% |
| Cost of Debt | 5.00% |
| WACC | 6.32% |